Likewise, Muraoka et al. [94] established that low-risk breast cancer patients have increased MFAP4 protein expression and suggested that MFAP4 can be a novel prognostic marker in the detection of breast cancer. This evidence concerns the gene MFAP4 and breast carcinoma.